BBVA vs HDB

BBVA's Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 3/9, signaling significant operational and balance sheet concerns. Despite this, the bank trades at a reasonable valuation with a P/E of 12.30 below the sector average of 21.13, and offers a solid 3.31% dividend yield supported by a sustainable 39.86% payout ratio. Profitability metrics like a 32.91% profit margin and 18.63% ROE are strong, but negative earnings growth and poor technical trend (10/100) offset these gains. The absence of Altman Z-Score data prevents a full distress risk assessment, but the low Piotroski score demands caution.

HDB exhibits a stable financial health profile with a Piotroski F-Score of 5/9, though it lacks an Altman Z-Score as is typical for banking institutions. The current price of $25.71 is almost perfectly aligned with its growth-based intrinsic value of $26.1, suggesting the stock has reached a fundamental floor after a severe correction. While the company maintains a strong track record of earnings surprises and a 'Strong Buy' analyst consensus, these are offset by negative YoY revenue growth and a completely bearish technical trend (0/100). The valuation is further complicated by an exceptionally high Price-to-Book ratio of 10.61, which is aggressive for the regional banking sector.